Trial Profile
Deferasirox for patients with advanced hepatocellular carcinoma : pilot study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Mar 2021
Price :
$35
*
At a glance
- Drugs Deferasirox (Primary)
- Indications Liver cancer
- Focus Adverse reactions
- 23 Mar 2021 Status changed from recruiting to completed.
- 10 Apr 2014 New trial record